The US Food and Drug Administration has approved enlicitide (Lipfendra) as the first oral PCSK9 inhibitor for reducing LDL ...
MSD has won the race to bring an oral PCSK9 inhibitor through to regulatory approval in the US, after getting the go-ahead ...
The FDA approved enlicitide (Lipfendra; Merck), the first oral PCSK9 inhibitor for lowering low-density lipoprotein ...
In patients with prior percutaneous coronary intervention, but no history of stroke or myocardial infarction, evolocumab reduces cardiovascular mortality. Evolocumab in stable patients with prior ...
Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Thomas J. Brock is a CFA and CPA with more than 20 years of experience in various areas ...
If you’re fascinated by government and want to contribute to the operation of cities, states and even the nation, an online public administration degree might be a solid choice for you. To find the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results